Terms: = Lung cancer AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808
11 results:
1. Low-grade undifferentiated sarcoma with MEIS1::ncoa2-rearrangement primary to the lung: a case report.
Coty-Fattal Z; Carter B; Volek MJ; Obeidin F
Diagn Pathol; 2024 Apr; 19(1):65. PubMed ID: 38678288
[TBL] [Abstract] [Full Text] [Related]
2. NR1D1-rearranged soft tissue tumour: A clinicopathological and molecular analysis of four additional cases.
Yin T; Zhu P; Lao IW; Yu L; Bai Q; Zhou X; Wang J
Histopathology; 2024 Mar; 84(4):661-670. PubMed ID: 38084644
[TBL] [Abstract] [Full Text] [Related]
3. Novel ncoa2/3-rearranged low-grade fibroblastic spindle cell tumors: A report of five cases.
Bakhshwin A; Armstrong SM; Duckworth LA; Stoehr R; Konishi E; Rubin BP; Fritchie KJ; Dickson BC; Agaimy A; Dermawan JK
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23203. PubMed ID: 37724942
[TBL] [Abstract] [Full Text] [Related]
4. Uterine MEIS1::ncoa2 Fusion Sarcoma With lung Metastasis: A Case Report and Review of the Literature.
Xing D; Meyer CF; Gross JM; Argani P; Hung CF; Wu TC; Vang R; Armstrong DK; Gaillard SL
Int J Gynecol Pathol; 2024 Jan; 43(1):47-55. PubMed ID: 37043646
[TBL] [Abstract] [Full Text] [Related]
5. Discovery and fine-mapping of height loci via high-density imputation of GWASs in individuals of African ancestry.
Graff M; Justice AE; Young KL; Marouli E; Zhang X; Fine RS; Lim E; Buchanan V; Rand K; Feitosa MF; Wojczynski MK; Yanek LR; Shao Y; Rohde R; Adeyemo AA; Aldrich MC; Allison MA; Ambrosone CB; Ambs S; Amos C; Arnett DK; Atwood L; Bandera EV; Bartz T; Becker DM; Berndt SI; Bernstein L; Bielak LF; Blot WJ; Bottinger EP; Bowden DW; Bradfield JP; Brody JA; Broeckel U; Burke G; Cade BE; Cai Q; Caporaso N; Carlson C; Carpten J; Casey G; Chanock SJ; Chen G; Chen M; Chen YI; Chen WM; Chesi A; Chiang CWK; Chu L; Coetzee GA; Conti DV; Cooper RS; Cushman M; Demerath E; Deming SL; Dimitrov L; Ding J; Diver WR; Duan Q; Evans MK; Falusi AG; Faul JD; Fornage M; Fox C; Freedman BI; Garcia M; Gillanders EM; Goodman P; Gottesman O; Grant SFA; Guo X; Hakonarson H; Haritunians T; Harris TB; Harris CC; Henderson BE; Hennis A; Hernandez DG; Hirschhorn JN; McNeill LH; Howard TD; Howard B; Hsing AW; Hsu YH; Hu JJ; Huff CD; Huo D; Ingles SA; Irvin MR; John EM; Johnson KC; Jordan JM; Kabagambe EK; Kang SJ; Kardia SL; Keating BJ; Kittles RA; Klein EA; Kolb S; Kolonel LN; Kooperberg C; Kuller L; Kutlar A; Lange L; Langefeld CD; Le Marchand L; Leonard H; Lettre G; Levin AM; Li Y; Li J; Liu Y; Liu Y; Liu S; Lohman K; Lotay V; Lu Y; Maixner W; Manson JE; McKnight B; Meng Y; Monda KL; Monroe K; Moore JH; Mosley TH; Mudgal P; Murphy AB; Nadukuru R; Nalls MA; Nathanson KL; Nayak U; N'Diaye A; Nemesure B; Neslund-Dudas C; Neuhouser ML; Nyante S; Ochs-Balcom H; Ogundiran TO; Ogunniyi A; Ojengbede O; Okut H; Olopade OI; Olshan A; Padhukasahasram B; Palmer J; Palmer CD; Palmer ND; Papanicolaou G; Patel SR; Pettaway CA; Peyser PA; Press MF; Rao DC; Rasmussen-Torvik LJ; Redline S; Reiner AP; Rhie SK; Rodriguez-Gil JL; Rotimi CN; Rotter JI; Ruiz-Narvaez EA; Rybicki BA; Salako B; Sale MM; Sanderson M; Schadt E; Schreiner PJ; Schurmann C; Schwartz AG; Shriner DA; Signorello LB; Singleton AB; Siscovick DS; Smith JA; Smith S; Speliotes E; Spitz M; Stanford JL; Stevens VL; Stram A; Strom SS; Sucheston L; Sun YV; Tajuddin SM; Taylor H; Taylor K; Tayo BO; Thun MJ; Tucker MA; Vaidya D; Van Den Berg DJ; Vedantam S; Vitolins M; Wang Z; Ware EB; Wassertheil-Smoller S; Weir DR; Wiencke JK; Williams SM; Williams LK; Wilson JG; Witte JS; Wrensch M; Wu X; Yao J; Zakai N; Zanetti K; Zemel BS; Zhao W; Zhao JH; Zheng W; Zhi D; Zhou J; Zhu X; Ziegler RG; Zmuda J; Zonderman AB; Psaty BM; Borecki IB; Cupples LA; Liu CT; Haiman CA; Loos R; Ng MCY; North KE
Am J Hum Genet; 2021 Apr; 108(4):564-582. PubMed ID: 33713608
[TBL] [Abstract] [Full Text] [Related]
6. Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis.
Dasgupta S; Putluri N; Long W; Zhang B; Wang J; Kaushik AK; Arnold JM; Bhowmik SK; Stashi E; Brennan CA; Rajapakshe K; Coarfa C; Mitsiades N; Ittmann MM; Chinnaiyan AM; Sreekumar A; O'Malley BW
J Clin Invest; 2015 Mar; 125(3):1174-88. PubMed ID: 25664849
[TBL] [Abstract] [Full Text] [Related]
7. Nuclear EGFR as a molecular target in cancer.
Brand TM; Iida M; Luthar N; Starr MM; Huppert EJ; Wheeler DL
Radiother Oncol; 2013 Sep; 108(3):370-7. PubMed ID: 23830194
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
[TBL] [Abstract] [Full Text] [Related]
9. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.
Ahn J; Albanes D; Berndt SI; Peters U; Chatterjee N; Freedman ND; Abnet CC; Huang WY; Kibel AS; Crawford ED; Weinstein SJ; Chanock SJ; Schatzkin A; Hayes RB;
Carcinogenesis; 2009 May; 30(5):769-76. PubMed ID: 19255064
[TBL] [Abstract] [Full Text] [Related]
10. Regulation of endogenous gene expression in human non-small cell lung cancer cells by estrogen receptor ligands.
Hershberger PA; Vasquez AC; Kanterewicz B; Land S; Siegfried JM; Nichols M
Cancer Res; 2005 Feb; 65(4):1598-605. PubMed ID: 15735050
[TBL] [Abstract] [Full Text] [Related]
11. Two distinct tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
Fryling CM; Iwata KK; Johnson PA; Knott WB; Todaro GJ
Cancer Res; 1985 Jun; 45(6):2695-9. PubMed ID: 2580626
[TBL] [Abstract] [Full Text] [Related]
